2022 Angel Oregon Life & Bioscience
AOBIO is a premier PNW life and bioscience investment program hosted by Oregon Entrepreneurs Network (OEN) in partnership with Oregon Bioscience Incubator, OHSU, and Oregon Bioscience Association.
Join us on March 30th, 2022 to meet the AOBIO investment candidates! This fastpitch event is the first step on the road to earning the more than $200K AOBIO investment. Meet the founders and see who is in the running. Co-hosted by Oregon Bioscience Association. Register FREE here.
AOBIO kicks off February 23rd with a four-week investment-readiness education series for life and bioscience startups at any stage of development. The program will feature local founders who have scaled successful companies in therapeutics, diagnostics, medical devices, or health innovation.
- Key pathways to scaling a life- or bioscience startup
- Lessons learned in building a bioscience company from experienced local founders
- How to create a case for investment to local and out of state investors
- What investors in the sector really want, and how to engage them successfully
At the end of the education program, those companies that are indeed investment-ready can apply to go through due diligence for a ~$300K equity angel investment, to be presented at the AOBIO Finale in May.
AOBIO Entrepreneur Registration – $95 OEN Members; $135 Non-Members, includes:
- Four core educational workshops featuring successful life and bio founders
- Office Hours and optional workshops with OBI Entrepreneurs in Residence
- Live AOBIO Mixer with mentors and investors in Portland
- Pitch practice opportunities and feedback from mentors and investors
- Opportunity to apply for ~$300K equity investment
- Ticket to the AOBIO Finale in May in Portland
February 23: Life & Bioscience Sector Map, with Holly Rockweiler, Madorra & Erik Tucker, Aronora, Presented by Oregon Health & Science University
This session will lay out a map of the life & bioscience sector, differentiating between therapeutics, medical devices, digital health, etc., and highlight implications for funding strategies (grant/non-dilutive funding, angel, venture, self, etc.), R&D, regulatory approvals, and go to market strategies for each.
March 2: Building the Bio Investment Case, with Patti White, Hemex Health, Emmanuel Akporiaye, Veana Therapeutics and Mike Fitzpatrick, Vector Remote Care, Presented by Perkins Coie
Map in hand, this session will go deeper on revenue models, phases of clinical trials or regulatory approvals if applicable, customer segmentation, sales and marketing strategies, product development roadmaps, etc. by specialty. The goal is to illuminate details – including potential challenges and pitfalls – to build a solid case for investment.
March 9: What Investors Really Want, with Ann Bunnenberg, Investor & John Harkness, Rewire Neuro, Presented by Vantage Point Advisors
Get it straight from the investors themselves: What’s the process and rhythm of equity fundraising? What do you need to prepare for due diligence? How do you approach the investor conversations?
March 16: What Does DEI Mean in Science Startups? with DeWayne Judd, Consultant and Himalaya Rao-Potlapally, Black Founders Matter
This session will foster a conversation about how race shows up in bioscience companies, and the implications and strategies for recruiting investors, team, and customers. We’ll also share details of the Emerge Initiative grant program for early stage founders of color.
Office Hours will be offered on Thursday mornings following each session, 9-10am, with Bill Newman and Gordon Hoffman, OBI Entrepreneurs in Residence.